Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Merck to lay off around 150 employees at US site amid slump in Gardasil sales
Merck is set to lay off approximately 150 employees at its North Carolina facility, which produces the HPV vaccine Gardasil, in response to a significant slump in sales. The company attributed this downturn to weak demand in China, leading to a 39% decrease in global sales in 2025, and a recent change in U.S. immunization recommendations for the vaccine. Merck’s management has indicated that Gardasil is no longer considered a key growth driver.